Particle design of Wogon extract dry powder for inhalation aerosols with granulation method

International Journal of Pharmaceutics

Volumn 168, Issue 1, 1998, Pages 59-68

  Hino, Tomoaki ^a   Serigano, Takanori ^a   Yamamoto, Hiromitsu ^a   Takeuchi, Hirofumi ^a   Niwa, Toshiyuki ^a   Kawashima, Yoshiaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Aerosol; Dry powder inhalation; Granulation; In vitro evaluation; Lung deposition patterns

Indexed keywords

ANTIASTHMATIC AGENT; CROMOGLYCATE DISODIUM; NATURAL PRODUCT; UNCLASSIFIED DRUG; WOGON EXTRACT;

AEROSOL; AIRFLOW; ARTICLE; CORRELATION FUNCTION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG FORMULATION; DRY POWDER; FLOW RATE; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032496608     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00083-0     Document Type: Article

References (14)

1. Biddiscombe M.F., Melchor R., Mak V.H.F., Marriott R.J., Taylor A.J., Short M.D., Spiro S.G. The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurised dose and dry powder inhalers. Int. J. Pharm. 91:1993;111-121.
2. British Pharmacopoeia, 1993. Her Majesty's Stationery Office, London. Appendix XVII-C, A194-A196.
3. Davies P.J., Hanlon G.W., Molyneux A.J. An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified 'Kirk Lung'. J. Pharm. Pharmacol. 28:1976;908-911.
4. Hinds, W.C., 1982. Uniform particle motion. In: Hinds, W.C. (Ed.), Aerosol Technology. Wiley-Interscience, New York, pp. 38-68.
5. Hino T., Serigano T., Yamamoto H., Takeuchi H., Niwa T., Kawashima Y. Assessment of inertial separation techniques used for pressurized metered dose inhalers to evaluate respiratory deposition of aerosolized Wogon extract dry powder in vitro. STP Pharma Sci. 7:1997;307-314.
6. Hiramatsu Y., Oka Y., Kiyama H. Rapid determination of the tensile strength of rocks with irregular test pieces. J. Mining Metallurgic. Inst. Jpn. 81:1965;1024-1030.
7. Kassem N.M., Shamat M.A., Duval C. The inspirable properties of a carrier-free dry powder aerosol formulation. J. Pharm. Pharmacol. 43:1991;75P.
8. Koda A., Nagai H., Yoshida Y., Lauw H.K. Pharmacological actions of baicalin and baicalein III: Effects on experimental asthma. Folia Pharmacol. Jpn. 66:1970;471-486.
9. Komada F., Iwakawa S., Yamamoto N., Sakakibara H., Okumura K. Intratracheal delivery of peptide and protein agent: Absorption from solution and fry powder by rat lung. J. Pharm. Sci. 83:1994;863-867.
10. Newman S.P., Hollingworth A., Clark A.R. Effect of different modes of inhalation on drug delivery from a dry powder inhaler. Int. J. Pharm. 102:1994;127-132.
11. Newitt D.M., Conway-Jones J.M. A contribution to the theory and practice of granulation. Trans. Inst. Chem. Eng. 36:1958;422-442.
12. Niwa T., Takeuchi H., Hino T., Kawashima Y. Aerosolization of lactide/glycolide copolymer (PLGA) nanospheres for pulmonary delivery of peptide-drugs. J. Pharm. Soc. Jpn. 115:1995;732-741.
13. Ralph, J.A., David, C.T., 1996. Physiology and pharmacology of the airways. In: Hickey, A.J. (Ed.), Inhalation Aerosols. Marcel Dekker, New York, pp. 85-137.
14. Timsina M.P., Martin G.P., Marriott C., Gamderton D., Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101:1994;1-13.